XO1

XO1 Ltd is a biotechnology companied formed specifically to develop ichorcumab. It is a virtual company, with no offices or laboratory space, and operates by engaging high quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers. Properly managed, virtual drug development not only controls costs but maximizes quality through flexible selection of the most appropriate supplier for each individual task. Read more: XO1 Ltd raises $11 million from Index Ventures to develop the 'holy grail' of anticoagulant drugs - FierceBiotech http://www.fiercebiotech.com/press-releases/xo1-ltd-raises-11-million-index-ventures-develop-holy-grail-anticoagulant-d#ixzz2WSG7D0Bu Subscribe at FierceBiotech

#SimilarOrganizations #People #Financial #Website #More

XO1

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical

Founded:

2013-04-01

Address:

Hatfield, Hertford, United Kingdom

Country:

United Kingdom

Website Url:

http://www.xo1.co.uk

Total Employee:

251+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

11 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Mobile Non Scaleable Content Amazon OpenResty AdBlock Acceptable Ads Bodis DNS

Similar Organizations

arna-genomics-logo

ARNA Genomics

ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.

dauntless-pharmaceuticals-logo

Dauntless Pharmaceuticals

Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

oxolife-logo

OXOlife

Oxolife is a biotechnology company in the clinical phase of development.

Founder

david-grainger_image

David Grainger

jim-huntington_image

Jim Huntington

trevor-baglin_image

Trevor Baglin

Investors List

index-ventures_image

Index Ventures

Index Ventures investment in Series A - XO1

limburgse-reconversie-maatschappij_image

Limburgse Reconversie Maatschappij

Limburgse Reconversie Maatschappij investment in Series A - XO1

Official Site Inspections

http://www.xo1.co.uk

Host Informations
Whois Informations

Loading ...

More informations about "XO1"

XO1 - Crunchbase Company Profile & Funding

Jun 17, 2013 Contact Email [email protected] XO1 Ltd is a biotechnology companied formed specifically to develop ichorcumab. It is a virtual company, with no offices or laboratory …See details»

Towards the ‘holy grail’ of anticoagulant drugs

Jun 17, 2013 A new spin-out company from the University of Cambridge and Addenbrooke’s Hospital, XO1 Ltd, has raised $11 million in funding to develop a new anticoagulant drug which has the potential to save millions of lives by …See details»

XO1 | VentureRadar

XO1 is a virtual biopharmaceutical company developing ichorcumab, an antibody against thrombin that delivers anticoagulation without bleeding. On March 19th 2015 XO1 was …See details»

XO1 Company Profile 2024: Valuation, Investors, …

XO1 was founded in 2012. Where is XO1 headquartered? XO1 is headquartered in High Wycombe, United Kingdom. What industry is XO1 in? XO1’s primary industry is Biotechnology. Is XO1 a private or public company? XO1 is a …See details»

XO1 LIMITED Company Profile | CAMBRIDGE, United Kingdom

Xo1 limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / cambridge …See details»

XO1 Ltd.: Drug pipelines, Patents, Clinical trials - Synapse

Jun 16, 2023 Explore XO1 Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

X01 and a ground-breaking drug candidate - Cambridge Enterprise

Oct 20, 2015 X01 Ltd, a spin-out company from the University of Cambridge and Cambridge University Hospitals, was established to develop a new anticoagulant drug, ichorcumab, which …See details»

XO1 - Ownership and Business Overview - Mergr

Mar 19, 2015 United Kingdom, www.xo1.co.uk. Profile Investors (1) Analytics XO1 Ltd. is an asset-centric virtual biopharmaceutical company. It is a developer of anti-thrombin antibody …See details»

Xo1 - Acquired by Janssen Pharmaceuticals (NASDAQ: JNJ)

XO1 is a virtual biopharmaceutical company developing ichorcumab, an antibody against thrombin that delivers anticoagulation without bleeding. CEO. Richard Mason. HQ. Cambridge, …See details»

XO1 LIMITED overview - Find and update company information

GOV.UK Find and update company information Companies House does not verify the accuracy of the information filed (link opens a new window) ... People for XO1 LIMITED (08424622) More …See details»

Janssen acquires XO1 Limited - manufacturingchemist.com

Mar 19, 2015 Janssen Pharmaceuticals, a division of Johnson & Johnson, has acquired XO1, a privately held virtual biopharmaceutical company founded to develop the anticoagulant drug …See details»

Janssen acquires XO1 Limited - Private Equity Wire

Mar 20, 2015 Janssen Pharmaceuticals has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin. ... UK PE firms …See details»

Janssen Pharmaceuticals acquires ichorcumab developer XO1 …

Ichorcumab was licensed by Cambridge Enterprise to XO1 in order to take its development towards the clinic. Johnson & Johnson Innovation head Patrick Verheyen said: "This …See details»

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor …

Jun 19, 2017 ApcinteX is completely different from XO1. It is built on observations in the clinic of patients with severe hemophilia who by chance co-inherited a common mutation known as the …See details»

Global Thought-Leaders in Anticoagulation Join XO1 Scientific …

Sep 20, 2013 Cambridge, Tuesday, 17 September 2013: Cambridge, UK, based biotech company XO1 Ltd has appointed Dr Richard Mason as Chief Executive Officer. Dr Mason will …See details»

XO1 Ltd. | Insights

Latest on XO1 Ltd. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To Biomedtracker. ... a Norstella company Pharma …See details»

XO1 Founding Management Team Re-Unite to Launch SuperX and …

Feb 9, 2017 CAMBRIDGE, UK / ACCESSWIRE / February 9, 2017 / SuperX Ltd, a biopharmaceutical company based in Cambridge, UK, announced today it has completed an …See details»

Xo1 Limited - Company Profile - Endole

Xo1 Limited is a dormant company located in . View company profile, shareholders, contacts, financials, industry and description. About Endole Solutions Pricing UPGRADE. Xo1 Limited. …See details»

XO1 - VentureRadar